WarrenD.J., OtienoL.S.. Carpal tunnel syndrome in patients on intermittent hemodialysis. Postgrad Med J1975; 51: 450–2.
2.
BrancaccioD., AnelliA.. Patologia da accumulo di B2 microglobulina. In: Cambi ed. Trattato Italiano di Dialisi.Milano: Wichtig Editore1990; II Vol: 1–16.
3.
GejyoF., HommaN., SaitoN., ArakawaM.. Carpal tunnel syndrome and Beta2-micro-globulin amyloidosis: histological and biochemical aspects. In: Dialysis Amyloidosis.Milano: Wichtig Editore1989; 35–6.
4.
HoltmannB., AndersonG.B.. Carpal tunnel syndrome following vascular shunts for hemodialysis. Archs Surg1977; 65: 112–5.
EllisJ.M., FolkersK., LevyM.. Response of vitamin B6 deficiency and the carpal tunnel syndrome to pyridoxine. Proc Natl Acad Sci USA1982; 79: 7494–8.
10.
AssenatH., CalemardE., CharraB.. Hemodialyse, syndrome du canal carpien et substance amyloide. Nouv Press Med1980; 9: 1715.
11.
GejyoF., YamadaT., OdaniS.. A new form of amyloid protein associated with chronic hemodialysis was identified as B2 -microglobulin. Biochem Biophys Res Commun1985; 129: 701–6.
De BroeM.E., NouvenJ., Van WaeleghenJ.P.. On the mechanism and site of production of Beta 2-microglobulin during hemodialysis. Nephrol Dial Transplant1987; 2: 124–5.
14.
BommerJ., SeeligP., SeeligR., GeerlingsW., BommerG., RitzE.. Determinants of plasma B2-microglobulin concentration: possible relation to membrane biocompatibility. Nephrol Dial Transplant1987; 2: 22–5.
15.
GhysenJ., DeplaenJ.F., Y-perseleVan, De StrihouC.. Effect of membrane characteristics on THF kinetics during hemodialysis (Abstract). XXVI Congress of EDTA-ERA. Goteborg 1989.
16.
ShaldonS., KochK.M., Dina-relloC.. Beta 2-microglobulin and hemodialysis. Lancet1987; i: 925–6.
17.
MahioutA., LudatK., GahlG., SchultzeG.. Effect of sodium dialysate concentration on B2-microglobulin during hemodialysis. Nephrol Dial Transplant1987; 2: 448.
18.
LornoyW., BecausI., BilliouwJ.H., SierensL., De WinterH., Van MalderenP.. Beta 2-microglobulin kinetics with six different permeability membranes in six anuric hemodialysis patients. Nephrol Dial Transplant1987; 2: 448.
19.
FlogeJ., GranollerasC., BingelM.. B2-microglobulin kinetics during hemodialysis and hemofiltration. Nephrol Dial Transplant1987; 1: 223–8.
20.
AnelliA., BrancaccioD., BarbestiS.. Labelled B2-microglobulin removal using different dialysis membranes. Nephrol Dial Transplant1987; 2: 446.
21.
AnelliA., GallieniM., PadoveseF., ColantonioG., BarbestiS., BrancaccioD.. B2-microglobu-lin adsorption an activated removal. In: AndreucciV.E., Dal CantonA. eds. Current therapy in Nephrology.Kluwer Academic Publisher1989; 239–41.
22.
WandelE., MarxM., MayetW., WeberM., KohelerH.. Serum Beta 2-microglobulin in patients in chronic hemodialysis with carpal tunnel syndrome. Nephrol Dial Transplant1987; 2: 450.
ConnorsL.H., ShirahamaT., SkinnerM., FenvesA., CohenA.S.. In vitro formation of amyloid fibrils from intact B2-mi-croglobulin. Biochem Biophys Comm Res1985; 31: 1063–8.
25.
GejyoF., ArakawaM.. New perspectives in dialysis amyloidosis. In: GejyoF., BrancaccioD., BardinR., eds. Dialysis A-myloidosis.Milano: Wichtig Editore1989; 147–53.